Cizzle Biotechnology (LON:CIZ) Shares Up 11.1% – Should You Buy?

Cizzle Biotechnology Holdings Plc (LON:CIZ) shot up 11.1% during mid-day trading on Thursday . The company traded as high as GBX 2.97 and last traded at GBX 2.80. 1,730,381 shares traded hands during mid-day trading, an increase of 60% from the average session volume of 1,078,764 shares. The stock had previously closed at GBX 2.52.

Cizzle Biotechnology Stock Up 21.0%

The company has a current ratio of 0.48, a quick ratio of 4.66 and a debt-to-equity ratio of -54.35. The stock’s 50-day moving average is GBX 2.04 and its 200-day moving average is GBX 1.73. The company has a market cap of £12.09 million, a price-to-earnings ratio of -17.94 and a beta of 0.51.

Cizzle Biotechnology (LON:CIZ) last released its earnings results on Tuesday, May 5th. The company reported GBX (0.17) earnings per share (EPS) for the quarter.

About Cizzle Biotechnology

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.